Henry Schein, Inc. (HSIC)
NASDAQ • Healthcare
Last close at September 30, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Henry Schein, Inc. keeps $3 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 33 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Henry Schein topped consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported on August 4, as revenue of $3.458 billion against a $3.374 billion estimate, +2.5%, and adjusted EPS of $1.27 versus $1.24, +2.4%. Revenue rose 6.7% to about $3.5 billion from about $3.2 billion a year ago, with gross margin near 32% and operating margin about 6% as operating income came to about $200 million. Net income climbed 9.3% to about $94 million from $86.0 million a year ago, while operating cash flow reached about $242 million and Henry Schein repurchased $200 million of stock. For the next period, consensus calls for adjusted EPS of $1.35 on revenue of $3.474 billion.
About Henry Schein, Inc.
Henry Schein, Inc. provides healthcare products and services to dental and medical settings and trades on the NASDAQ under HSIC. The company operates in healthcare distribution and related practice technology, and it generated $13.2 billion of revenue in FY2025 across a global customer base.
Today's Snapshot
The day ended with HSIC 1.2% lower at 83.97, in line with a weaker sector. Volume was about two-thirds of its usual level.
Trading Volume
Below 10d avg (1.3M)
857.1K
vs S&P 500 Today
Underperforming Market
-1.37%
Updated: September 30, 2026 at 20:17 UTC
HSIC Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$80.28 - $86.58Sell
- RSI (14)38.11Neutral
- Stochastic %K (14, 3, 3)18.54Buy
- MACD Level (12, 26)-0.91Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.